###begin article-title 0
###xml 51 56 <span type="species:ncbi:9606">human</span>
Implications of a RAD54L polymorphism (2290C/T) in human meningiomas as a risk factor and/or a genetic marker
###end article-title 0
###begin title 1
Background
###end title 1
###begin p 2
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RAD54L </italic>
###xml 214 221 214 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RAD54L </italic>
###xml 784 792 <span type="species:ncbi:9606">patients</span>
RAD54L (OMIM 603615, Locus Link 8438) has been proposed as a candidate oncosupressor in tumours bearing a non-random deletion of 1p32, such as breast or colon carcinomas, lymphomas and meningiomas. In a search for RAD54L mutations in 29 menigiomas with allelic deletions in 1p, the only genetic change observed was a silent C/T transition at nucleotide 2290 in exon 18. In this communication the possible association of the 2290C/T polymorphism with the risk of meningiomas was examined. In addition, the usefulness of this polymorphism as a genetic marker within the meningioma consensus deletion region in 1p32 was also verified. The present study comprises 287 blood control samples and 70 meningiomas from Spain and Ecuador. Matched blood samples were only available from Spanish patients.
###end p 2
###begin title 3
Results
###end title 3
###begin p 4
###xml 324 330 324 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RAD54L</italic>
###xml 530 537 530 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RAD54L </italic>
###xml 575 582 575 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RAD54L </italic>
###xml 117 125 <span type="species:ncbi:9606">patients</span>
The frequency of the rare allele-T and heterozygotes for the 2290C/T polymorphism in the blood of Spanish meningioma patients and in the Ecuadorian meningioma tumours was higher than in the control population (P < 0.05). Four other rare variants (2290C/G, 2299C/G, 2313G/A, 2344A/G) were found within 50 bp at the 3' end of RAD54L. Frequent loss of heterozygosity for the 2290C/T SNP in meningiomas allowed to further narrow the 1p32 consensus region of deletion in meningiomas to either 2.08 Mbp - within D1S2713 (44.35 Mbp) and RAD54L (46.43 Mbp) - or to 1.47 Mbp - within RAD54L and D1S2134 (47.90 Mbp) - according to recent gene mapping results.
###end p 4
###begin title 5
Conclusion
###end title 5
###begin p 6
The statistical analysis of genotypes at the 2290C/T polymorphism suggest an association between the rare T allele and the development of meningeal tumours. This polymorphism can be used as a genetic marker inside the consensus deletion region at 1p32 in meningiomas.
###end p 6
###begin title 7
Background
###end title 7
###begin p 8
###xml 279 280 279 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 391 392 391 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 699 700 699 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 701 702 701 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 985 986 985 986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 987 988 987 988 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 989 990 989 990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1236 1238 1236 1238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1450 1452 1450 1452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 573 581 <span type="species:ncbi:9606">patients</span>
Meningiomas are slow-growing tumours derived from the arachnoid membrane surrounding the central nervous system. They are one of the commonest intracranial tumours, accounting for 20% of all brain tumours, with an overall incidence of 2.3/100,000 and a 2:1 female-to-male ratio [1]. The frequent finding of asymptomatic meningiomas in computerised tomography and magnetic resonance studies [2] will probably raise these prevalence figures. A close relationship exists between meningiomas and neurofibromatosis type II (NF2). Meningiomas have been found in more than 50% of patients with this common hereditary disorder and sporadic meningiomas show frequent mutations in the NF2 oncosupressor gene [3-5]. Besides NF2, other candidate genes are suspected to be involved in the multistep development of meningiomas; among these genes are those presumably inactivated by deletion/mutation in 1p32, a region of frequent loss of heterozygosity (LOH) in sporadic and hereditary meningiomas [4,6-9]. Mapped at 1p32 and with likely functions in mitotic and meiotic recombination, RAD54L (OMIM 603615, Locus Link 8438), a member of the SNF2/SWI2 family of DNA-dependent ATPases, has been proposed as a candidate oncosupressor in breast tumours [10]. The finding of mutations in a small fraction of breast carcinomas (1 out of 95 tumours), colon carcinomas (1 out of 13 tumours) and lymphomas (1 out of 24) supports the involvement of RAD54L in tumorigenesis [11].
###end p 8
###begin p 9
###xml 147 155 147 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RAD54 L </italic>
###xml 282 284 282 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 525 532 525 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RAD54L </italic>
###xml 1009 1010 1009 1010 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
In a previous single strand conformation polymorphism (SSCP) analysis of 29 meningiomas with 1 p deletions we failed to detect any mutation in the RAD54 L gene, but found instead a silent C/T polymorphism (Ala730Ala) that was identified by direct sequencing of PCR-amplified exons [12]. This polymorphism has been independently identified (NCB SNP cluster ID: rs1048771) in chromosome 1 contig NT_004386 using high output methods for SNP detection. Blast analysis has unequivocally linked the variation to nucleotide 2290 of RAD54L mRNA (Gen Bank accession X97795.1) or to nucleotide position 2851 in the NCBI RefSeq (accession NM_003579.2); however, lack of information regarding population genotype and allele frequency has precluded its validation as an SNP marker. In this communication the possible association of 2290C/T polymorphism with the risk of meningiomas was examined. In addition, the usefulness of this polymorphism as a genetic marker within the meningioma consensus deletion region in 1p32 [6] was also ascertained.
###end p 9
###begin title 10
Methods
###end title 10
###begin title 11
Tissue samples
###end title 11
###begin p 12
###xml 139 140 139 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 141 143 141 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 347 357 347 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. Espejo </italic>
###xml 361 378 361 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. Andrade Mar&#237;n </italic>
###xml 105 113 <span type="species:ncbi:9606">patients</span>
###xml 519 527 <span type="species:ncbi:9606">patients</span>
Twenty-nine Spanish tumours with deletions in 1p and matched blood samples were obtained from meningioma patients as previously described [5,12]. Forty-one paraffin archival, randomly-chosen, samples of meningiomas (20 meningothelial, 11 transitional, 5 fibroblastic, 3 psamomatose and 2 angioblastic) were obtained from the pathology services of E. Espejo and C. Andrade Marin hospitals in Quito, Ecuador. Two of them were grade II and 39 grade I, according the WHO Classification. No matched blood samples from those patients were available. Spanish and Ecuadorian blood control were obtained from healthy transfusion blood donors.
###end p 12
###begin title 13
DNA extraction
###end title 13
###begin p 14
###xml 87 88 87 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 89 91 89 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 170 172 170 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
Genomic DNA was prepared from frozen tissues by standard methods previously described [5,12]. DNA from paraffin-embedded samples was extracted by standardised protocols [13]. DNA from peripheral lymphocytes was extracted using a DNA-extraction kit from Stratagene, according to the manufacturer's protocol.
###end p 14
###begin title 15
PCR based analysis of RAD54L polymorphism and 1p polymorphic markers
###end title 15
###begin p 16
###xml 160 162 160 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 269 271 269 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 343 344 343 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 345 347 345 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
The allelic status of 2290 C/T polymorphism in tumour and blood samples was ascertained by PCR amplification of exon 18 followed by SSCP analysis as described [12]. On some occasions confirmatory direct sequencing analysis of PCR products was carried out as described [12]. The allelic status at microsatellite loci was analysed as described [5,12].
###end p 16
###begin title 17
Statistical analysis
###end title 17
###begin p 18
Epidemiological variables and genotypes were evaluated using Tukey-Kramer comparison tests, Odds ratios and Fisher's two-sided exact test.
###end p 18
###begin title 19
Results and discussion
###end title 19
###begin p 20
###xml 318 319 318 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 1113 1114 1113 1114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 1115 1116 1115 1116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 365 373 <span type="species:ncbi:9606">patients</span>
###xml 443 451 <span type="species:ncbi:9606">patients</span>
###xml 637 645 <span type="species:ncbi:9606">patients</span>
###xml 972 980 <span type="species:ncbi:9606">patients</span>
In order to validate the SNP status of the 2290 C/T polymorphism we have extended our previous observations with the analysis of additional Spanish control population (up to 87 healthy blood donors) and have also included a new control group of 149 healthy blood donors and 41 menigioma samples from Ecuador. In Table 1 we summarise the epidemiological data of the patients included in this study. The sex ratio in both Ecuadorian and Spanish patients (2.7 and 3.1 female/male ratio, respectively) is higher than that reported for larger populations. The age at diagnostic is similar in the Ecuadorian sex groups and in the Spanish male patients, but is higher in the Spanish female group. Marked differences were also observed in tumour histopathology. While most of the Ecuadorian meningiomas were of WHO grade I, the Spanish tumours were of a predominant grade II-III histology. These dissimilarities originate from the selection criterion used in selecting meningioma patients - random in Ecuador, LOH for 1p markers in Spain - and the well established correlation between 1p loss and meningioma progression [5,6].
###end p 20
###begin p 21
###xml 28 36 <span type="species:ncbi:9606">patients</span>
Stratification of menigioma patients by sex, age, grade, and histology
###end p 21
###begin p 22
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a </sup>
###xml 113 115 113 115 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b </sup>
###xml 140 141 140 141 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c</sup>
a Tukey-Kramer Multiple Comparison Test for age and sex comparison. Fisher's Exact Test for grade and histology. b n.s., "not significant". c n.a,, "not available".
###end p 22
###begin p 23
###xml 18 19 18 19 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 263 270 263 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RAD54L </italic>
###xml 558 559 558 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 585 586 585 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 1427 1429 1427 1429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1563 1564 1563 1564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 1581 1582 1581 1582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 1593 1594 1593 1594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 1804 1805 1804 1805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 1806 1807 1806 1807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 306 314 <span type="species:ncbi:9606">patients</span>
###xml 443 451 <span type="species:ncbi:9606">patients</span>
###xml 676 684 <span type="species:ncbi:9606">patients</span>
###xml 859 866 <span type="species:ncbi:9606">patient</span>
###xml 1285 1292 <span type="species:ncbi:9606">patient</span>
###xml 1878 1886 <span type="species:ncbi:9606">patients</span>
###xml 2285 2293 <span type="species:ncbi:9606">patients</span>
As shown in Table 2, heterozygotes and T-allele frequencies were statistically indistinguishable in control population groups from Ecuador and. In both cases the results conform to the Hardy and Weinberg equation. We have also measured allele frequencies for the RAD54L 2290 C/T polymorphism in meningioma patients from Spain and Ecuador. The Spanish group included. 29 tumour samples with 22 matched peripheral blood samples from a subset of patients with LOH for at least one marker of chromosome 1p and prevailing atypical/anaplastic histology (see Table 1) as previously reported [5]. Heterozygosity and T-allele frequencies were higher in the lymphocyte DNA from Spanish patients (P = 0.0036 and 0.0037, respectively) as compared with the Spanish control population. The heterozygosity in the Spanish meningeal tumours (0.069) was much lower than in the patient's peripheral blood (0.500) and in Ecuadorian tumours (0.732). This discrepancy is an expected consequence of the selection criterion for the Spanish meningioma (LOH for at least one marker of 1p) and the frequent loss of heterozygosity (9/11 informative cases, 82%) observed for the 2290C/T polymorphism in this tumour group. The frequency of the rare T-allele (0.22) in the Spanish meningioma group is similar to the patient's blood and higher than in the healthy controls. Similar frequency has been reported in a mutational study of several tumour samples [11]. The meningeal tumours from Ecuador, consisting of 41 archival paraffin samples with a predominant WHO grade I histology (see Table 1) showed (Figure 1 and Table 2) a very high rate of heterozygosity, amounting to 73% of this group versus 20% in the control Ecuadorian population. Although the predominantly typical histology would suggest a low incidence of 1p deletions [5,6] in these tumour samples, the unavailability of blood from Ecuadorian patients prevented the ascertainment of LOH and hemizygosity in the tumour samples and, as a result, the frequency of the C-allele was probably overestimated. Even with this drawback, the frequency of heterozygosis and T-alleles was very high and extremely significant when compared with the Ecuadorian control population (P = 0.0001). The similitude between Ecuadorian tumours and the constitutive Spanish patients genotypes, with higher heterozygosity and T-allele frequency than their healthy population controls are noteworthy, and suggest the presence of an association between the 2290T-allele and the development of meningeal tumours.
###end p 23
###begin p 24
###xml 0 62 0 62 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Status of the 2290C/T polymorphism in meningiomas from Ecuador</bold>
Status of the 2290C/T polymorphism in meningiomas from Ecuador. DNA was extracted from paraffin archival and 2290 C/T alleles were characterised by PCR-SSCP as described in methods. The figure shows a representative SSCP of 37 cases. Arrowhead point to T and C alleles migration in the gel.
###end p 24
###begin p 25
###xml 171 173 171 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 77 85 <span type="species:ncbi:9606">patients</span>
Heterozygotes and T-allele frequencies in population controls and meningioma patients. Alleles were identified by exon 18 PCR amplification followed by SSCP as described [12].
###end p 25
###begin p 26
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a </sup>
###xml 86 88 86 88 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b </sup>
###xml 187 189 187 189 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c </sup>
###xml 262 264 262 264 <sup xmlns:xlink="http://www.w3.org/1999/xlink">d </sup>
###xml 394 399 394 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 415 417 415 417 <sup xmlns:xlink="http://www.w3.org/1999/xlink">e </sup>
###xml 484 486 484 486 <sup xmlns:xlink="http://www.w3.org/1999/xlink">f </sup>
###xml 264 272 <span type="species:ncbi:9606">Patients</span>
###xml 357 365 <span type="species:ncbi:9606">patients</span>
###xml 586 594 <span type="species:ncbi:9606">patients</span>
a Number of heterozygotes / number of cases or tumour samples. Frequency in brackets. b Odds Ratio (OR) with 95% confidence values in brackets and P value (two-sided Fisher's exact test) c Number of T-alleles / total chromosomes in group. Frequency in brackets. d Patients selected for LOH in 1p markers in tumour samples. Blood was unavailable in 7 of the patients. Data revised from Mendiola et al. 1999 (ref. 12)e Number of chromosomes is reduced to 49 for LOH found in 9 samples. f Archival paraffin samples as described in the methods. Hemizygosis was not evaluable due to lack of patients' blood.
###end p 26
###begin p 27
###xml 82 89 82 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RAD54L </italic>
###xml 122 123 122 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 318 324 318 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RAD54L</italic>
###xml 408 409 408 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 537 538 537 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 654 655 654 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 748 749 748 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 1118 1124 1118 1124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RAD54L</italic>
Besides the 2290C/T polymorphism, other rare variants were found at the 3' end of RAD54L exon 18, as summarised in Figure 2, together with the mismatches (boxes 1, 4 and 5 in the figure) between genomic and mRNA sequences already reported in the NCBI database (Evidence View, graphic display option) when searched for RAD54L. Besides the 2290C/T polymorphism, a new silent 2290C/G variant (box 1-2 in Figure 2) has been found in 1 out of the 11 sequenced Ecuadorian meningeal tumours. Another new 2299C/G, F733L variant (box 3 in Figure 2) has been found with a low frequency (1/11) in Ecuadorian tumours. The 2313G/A, R738H variant (box 4 in the figure 2) has already been reported as a mismatch. Finally, a new 2344A/G variation (box 6 in Figure 2) replaces the 747-stop codon with a tryptophan and displaced the protein termination signal to the next TAA codon in position 748. This variation has been found in the Ecuadorian (1/11) and Spanish (1/13) samples. The high density of variations found in exon 18 (5 in 52 nucleotides) is noteworthy and suggests the occurrence of a genomic instability at the 3' end of RAD54L.
###end p 27
###begin p 28
###xml 38 45 38 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RAD54L </italic>
###xml 70 77 70 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RAD54L </italic>
###xml 81 86 81 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MUF1 </italic>
###xml 0 137 0 137 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Variants and mismatches in exon 18 of <italic>RAD54L </italic>and molecular linkage of <italic>RAD54L </italic>and <italic>MUF1 </italic>through an inverse overlapping of untranslated mRNA</bold>
###xml 306 312 306 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RAD54L</italic>
###xml 463 469 463 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RAD54L</italic>
###xml 633 640 633 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RAD54L </italic>
###xml 644 649 644 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MUF1 </italic>
Variants and mismatches in exon 18 of RAD54L and molecular linkage of RAD54L and MUF1 through an inverse overlapping of untranslated mRNA. In the upper side of the figure, variants found in meningiomas (numbered 1-2, 3, 4, 5 and 6) and mismatches reported in the NCBI (Evidence Viewer, graphic display for RAD54L) (1, 4 and 5) are shown in bold within green boxes. The figure displays from top to bottom: the reference protein (Rp) and mRNA (Rs) at the 3' end of RAD54L, the variants and mismatches (Vr) and their corresponding protein sequences (Vp). In the lower part of the figure the inverse overlapping 70 bp sequence shared by RAD54L and MUF1 3'UTR is shown. Figures in brackets correspond to nucleotide positions in the NT_004386 contig.
###end p 28
###begin p 29
###xml 171 172 171 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 436 437 436 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 465 466 465 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 467 469 467 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 782 783 782 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 1004 1011 1004 1011 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RAD54L </italic>
###xml 1047 1054 1047 1054 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RAD54L </italic>
###xml 1078 1079 1078 1079 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 1211 1217 1211 1217 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GROS1 </italic>
###xml 1218 1220 1218 1220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1295 1302 1295 1302 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKN2C </italic>
###xml 1303 1305 1303 1305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1325 1332 1325 1332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKNC2 </italic>
###xml 1429 1430 1429 1430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1433 1438 1433 1438 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAL1 </italic>
###xml 1439 1441 1439 1441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1447 1451 1447 1451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SIL </italic>
###xml 1452 1454 1452 1454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1525 1526 1525 1526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 1623 1629 1623 1629 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RAD54L</italic>
###xml 1729 1734 1729 1734 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTCH2</italic>
###xml 1736 1742 1736 1742 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MUTYH </italic>
###xml 1746 1750 1746 1750 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MUF1</italic>
###xml 1752 1758 1752 1758 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTCH2 </italic>
###xml 1928 1930 1928 1930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1933 1939 1933 1939 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MUTYH </italic>
###xml 2048 2050 2048 2050 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 2081 2086 2081 2086 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MUTL </italic>
###xml 2166 2171 2166 2171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MUF1 </italic>
###xml 2291 2294 2291 2294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VHL</italic>
###xml 2404 2406 2404 2406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 107 115 <span type="species:ncbi:9606">patients</span>
###xml 1794 1799 <span type="species:ncbi:9606">human</span>
###xml 1813 1823 <span type="species:ncbi:7227">Drosophila</span>
###xml 1990 1995 <span type="species:ncbi:4932">yeast</span>
The high frequency of constitutional heterozygosity in the 2290C/T alleles found in a subset of meningioma patients with deletions in the short arm of chromosome 1 (Table 1) together with the frequent loss of heterozygosity for the 2290C/T alleles in the Spanish meningeal tumours (82% of the informative cases), suggests that this SNP could be used as a 1p32 marker inside the critical 1.5 cM consensus deletion region in meningiomas [6]. Using our own published [5,12] and unpublished (Mendiola. Chemistry MS thesis, UAM, Madrid, 1999) data, together with recent information on the sequence map for chromosome 1 (available through the web of the NCBI, Entrez Genome and UniSTS, updated as of September 2002), we were able to identify 2 tumour samples (numbers 13 and 14 in figure 3) in which the LOH for the 2290C/T SNP marker further reduced the 1p32 consensus region for deletion in menigiomas (3.55 Mbp) within D1S2713 (44.35 Mpb) and D1S2134 (47.90 Mbp), to either the 2.08 Mbp between D1S2713 and RAD54L (46.43 Mpb) or the 1.47 Mbp between RAD54L and D1S2134 (see Figure 3). This narrowed definition of the minimal region of allelic loss excludes candidate genes telomeric to D1S211 (44.07 Mbp), such as GROS1 [15], mapped at 43.3 Mbp, or genes centromeric to D1S197 (51,70 Mbp), such as CDKN2C [16]. The exclusion of CDKNC2 as a candidate oncosupressor in meningiomas has also been suggested in recent molecular studies [9]. TAL1 [17] and SIL [18], which map at 50.20 Mbp within the consensus deletion region (Figure 3), have proto-oncogen functions in leukaemia, and are unlikely oncosupressor candidates. Besides RAD54L, other oncosupressor candidates mapping within the smallest region of overlap (D1S2713-RAD54L) are PTCH2, MUTYH and MUF1. PTCH2 (OMIM 603673, Locus Link 8643), the human homologue of Drosophila patched-hedgehog, has been implicated in malignancies such as medulloblastoma and basal cell carcinoma [19]. MUTYH (OMIM 604933, Locus Link 4595), a homologue of the yeast mutY gene, is an oxidative mismatch repair protein [20] which could be involved with MUTL in susceptibility to hereditary nonpolyposis colon cancer (HNPCC, OMIM 120535). MUF1 (Locus Link 10489) has recently been characterised as an Elongin BC-interacting protein, akin to the Von Hippel Landau (VHL) tumour supressor protein in its ability to assemble with Cul5 and Rbx1 and reconstitute a ubiquitin ligase [21]. To our knowledge none of these putative candidate genes has been studied in meningiomas.
###end p 29
###begin p 30
###xml 0 45 0 45 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Summary of LOH analysis and map information. </bold>
###xml 276 277 276 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 299 306 299 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RAD54L </italic>
###xml 697 704 697 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RAD54L </italic>
###xml 572 579 <span type="species:ncbi:9606">Patient</span>
###xml 662 670 <span type="species:ncbi:9606">patients</span>
Summary of LOH analysis and map information. A. Sequence maps of 1p markers and genes were obtained from NCBI gene maps and UniSTS records (updated as of September 2002). Salmon coloured horizontal lines delimit the smallest overlapping region flanked by D1S2713 and D1S2134 [6]. LOH results for 11 RAD54L polymorphism informative cases are taken from previous published and unpublished results (see the text). Open and closed circles correspond to retention and loss of heterozygosity respectively. The horizontal bar represents uninformative constitutional homozygosis. Patient identification as in ref. 5. B. SSCP of constitutive (C) and tumoral (T) DNA from patients 13 and 14, showing LOH of RAD54L and retention of heterozygosity for D1S197 and D1S232 markers.
###end p 30
###begin p 31
###xml 128 129 128 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 591 598 591 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RAD54L </italic>
###xml 602 607 602 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MUF1 </italic>
###xml 757 758 757 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 916 918 916 918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 919 921 919 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1047 1054 1047 1054 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RAD54L </italic>
###xml 1062 1067 1062 1067 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MUF1 </italic>
###xml 1197 1204 1197 1204 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RAD54L.</italic>
The statistical association between the rare T allele in the 2290C/T polymorphism and the risk of meningioma development (Table 1) requires some attention. It is unlikely that the 2290C/T silent variation (Ala730Ala) could result in functionally different alleles, and there is no evidence for any plausible effect on mRNA transcription. Alternatively, it is possible that the T-allele is in linkage disequilibrium with another sequence of DNA directly implicated in tumour development. According to the draft chromosome 1 sequence (accession NT_004386, in Entrez Nucleotide from NCBI web), RAD54L and MUF1 share 69 bp of a convergent and inverted untranslated mRNA that contains the poly (A+) signal and the site for polyadenylation for both genes (Figure 2). This is a condition for dsRNA production that could initiate a chain reaction of gene silencing through degradation of homologous messenger RNA molecules [22,23]. Whether the 2290T-allele is actually linked to a gene silencing mechanism through homologous antisense dsRNA of either the RAD54L mRNA or MUF1 mRNA would require dilucidation in further studies, which also have to consider the genomic instability observed at the 3' end of RAD54L.
###end p 31
###begin title 32
Conclusions
###end title 32
###begin p 33
###xml 77 85 <span type="species:ncbi:9606">patients</span>
The statistical analysis of genotype (2290C/T) distribution among meningioma patients and healthy controls suggests that the rare T allele is associated with the risk of meningioma development. In addition, this study also shows that the 2290C/T variation can succesfully be exploited as a polymorphic marker inside the consensus deletion at 1p32 in meningiomas.
###end p 33
###begin title 34
List of abbreviations
###end title 34
###begin p 35
PCR (polymerase chain reaction), SSCP (single stranded chain polymorfism), LOH (loss of heterozygosity), SNP (single nucleotide polymorphism)
###end p 35
###begin title 36
Competing interests
###end title 36
###begin p 37
None declared.
###end p 37
###begin title 38
Authors' contributions
###end title 38
###begin p 39
PEL and CPM processed and analyzed tissue and blood samples from Ecuador. MM and JA processed the Spanish samples. AP coordinated the study and drafted the manuscript.
###end p 39
###begin title 40
Web links
###end title 40
###begin p 41
###xml 0 7 0 7 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Entrez </bold>
Entrez  is the NCBI common retrieval system for SNP, UniSTS, OMIM, nucleotide, genome and other databases.
###end p 41
###begin p 42
###xml 0 10 0 10 <bold xmlns:xlink="http://www.w3.org/1999/xlink">LocusLink </bold>
LocusLink  is the NCBI iterface for search curated sequences and information about genetic loci.
###end p 42
###begin title 43
Pre-publication history
###end title 43
###begin p 44
The pre-publication history for this paper can be accessed here:
###end p 44
###begin p 45

###end p 45
###begin title 46
Acknowledgements
###end title 46
###begin p 47
This work was supported by grants from the Spanish Ministry of Education and Science (Programa de Cooperacion Cientifica con Iberoamerica). MM is a fellow from the Spanish Ministry of Health (Fondo de Investigacion Sanitaria). We are indebted to Paola Nebreda and Javier Perez for able technical assistance in processing tissue specimens and drawings, respectively. The careful reading of the manuscript by Brenda Ashley is also acknowledged.
###end p 47
###begin article-title 48
Epidemiology and etiology of intracranial meningiomas: a review.
###end article-title 48
###begin article-title 49
Incidence and clinical features of asymptomatic meningiomas.
###end article-title 49
###begin article-title 50
Molecular genetic investigation of the neurofibromatosis type 2 tumor suppressor gene in sporadic meningioma.
###end article-title 50
###begin article-title 51
Allelic loses in neurofibromatosis 2-associated meningiomas.
###end article-title 51
###begin article-title 52
NF2 mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas.
###end article-title 52
###begin article-title 53
Identification of a consistent region of allelic loss on 1p32 in meningiomas: correlation with increased morbidity.
###end article-title 53
###begin article-title 54
1p and 3p deletions in meningiomas without detectable aberrations of chromosoma 22 identified by comparative genomic hybridization.
###end article-title 54
###begin article-title 55
Chromosomal deletion in anaplastic meningiomas suggest multiple regions outside chromosome 22 as important in tumor progression.
###end article-title 55
###begin article-title 56
Frequent loss of 1p32 region but no mutation of the p18 tumor suppressor gene in meningioma.
###end article-title 56
###begin article-title 57
###xml 24 29 <span type="species:ncbi:9606">human</span>
Characterization of the human homologue of RAD54: a gene located on chromosome 1p32 at a region of high loss of heterozygosity in breast tumors.
###end article-title 57
###begin article-title 58
Mutations in the RAD54 recombination gene in primary cancers.
###end article-title 58
###begin article-title 59
Search for mutations of the hRAD54 gene in sporadic meningiomas with deletion at 1p32.
###end article-title 59
###begin article-title 60
Diagnostic Molecular Pathology: A Practical Approach.
###end article-title 60
###begin article-title 61
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 10 15 <span type="species:ncbi:10090">mouse</span>
###xml 32 56 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Human and mouse homologs of the Saccharomyces cerevisiae RAD54 DNA repair gene: evidence for functional conservation.
###end article-title 61
###begin article-title 62
Gros1, a potential grwth suppresor on chromosome 1: its identity to basement membrane-associated proteoglycan, leprecan.
###end article-title 62
###begin article-title 63
###xml 35 40 <span type="species:ncbi:9606">human</span>
Structure of the gene encoding the human cyclin-dependent kinase inhibitor p18 and mutational analysis in breast cancer.
###end article-title 63
###begin article-title 64
###xml 54 60 <span type="species:ncbi:10090">murine</span>
###xml 76 81 <span type="species:ncbi:9606">human</span>
Molecular cloning and chromosomal localization of the murine homolog of the human helix-loop-helix gene SCL.
###end article-title 64
###begin article-title 65
###xml 142 157 <span type="species:ncbi:10090">transgenic mice</span>
An scl gene product lacking the transactivation domain induces bony abnormalities and cooperates with LMO1 to generate T-cell malignancies in transgenic mice.
###end article-title 65
###begin article-title 66
###xml 34 39 <span type="species:ncbi:9606">human</span>
Isolation and characterization of human patched 2 (PTCH2), a putative tumour suppressor gene in basal cell carcinoma and medulloblastoma on chromosome 1p32.
###end article-title 66
###begin article-title 67
###xml 25 30 <span type="species:ncbi:9606">human</span>
###xml 53 69 <span type="species:ncbi:562">Escherichia coli</span>
Cloning and sequencing a human homolog (hMYH) of the Escherichia coli mut Y gene whose function is required for the repais of oxidative DNA damage.
###end article-title 67
###begin article-title 68
Muf1, a novel Elongin BC-interacting leucine-rich repeat protein that can assemble with Cul5 and Rbx1 to reconstitute a ubiquitin ligase.
###end article-title 68
###begin article-title 69
Gene silencing by double-stranded RNA.
###end article-title 69
###begin article-title 70
A short primer on RNAi: RNA-directed RNA polymerase acts as a key catalist.
###end article-title 70

